A transdiagnostic meta-analysis of physical and social Anhedonia in major depressive disorder and schizophrenia spectrum disorders

被引:11
|
作者
Gandhi, Arti [1 ]
Mote, Jasmine [2 ]
Fulford, Daniel [1 ,3 ]
机构
[1] Boston Univ, Sargent Coll Hlth & Rehabil Sci, 635 Commonwealth Ave, Boston, MA 02215 USA
[2] Tufts Univ, Sch Arts & Sci, Dept Occupat Therapy, 574 Boston Ave, Medford, MA 02155 USA
[3] Boston Univ, Dept Psychol & Brain Sci, 900 Commonwealth Ave, Boston, MA 02215 USA
关键词
Anhedonia; Schizophrenia; Depression; COGNITIVE CONTROL; NEURAL RESPONSE; SELF-ASSESSMENT; DEFICITS; EXPERIENCE; PEOPLE; REWARD; MOTIVATION; SYMPTOMS; PLEASURE;
D O I
10.1016/j.psychres.2021.114379
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Introduction: Anhedonia is a transdiagnostic construct conceptualized as physical or social, however, the extent to which these subtypes differ across psychotic and mood pathology remains poorly understood. We aimed to quantify the severity of physical and social anhedonia across Major Depressive Disorder (MDD) and Schizophrenia Spectrum Disorder (SSDs). Methods: We conducted meta-analyses of the Chapman Physical and Social Anhedonia Scales (PAS;SAS). We reviewed data from participants with MDD, and SSDs separately. Results: Our first meta-analysis (n = 8 studies, 409 participants) with MDD revealed elevated SAS and PAS in MDD compared to controls. Within-group differences were not significant. Depressive symptom severity moderated the between-group effect of PAS. Our second meta-analysis (n = 44 studies, 3352 participants) revealed elevated SAS and PAS in SSDs compared to controls. We detected a moderate difference between the SAS and PAS within the SSD group. Age moderated within-group differences of SAS and PAS. Discussion: People with SSD or MDD experience elevated SAS and PAS compared to controls. People with SSDs endorse greater challenges experiencing social rewards relative to physical rewards. People with MDD experience social and physical rewards similarly. The moderating role of depressive symptoms in MDD suggests that physical anhedonia is more state-like than social anhedonia.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Meta-analysis of emotion recognition deficits in major depressive disorder
    Dalili, M. N.
    Penton-Voak, I. S.
    Harmer, C. J.
    Munafo, M. R.
    PSYCHOLOGICAL MEDICINE, 2015, 45 (06) : 1135 - 1144
  • [42] The effect of treatment as usual on major depressive disorder: A meta-analysis
    Kolovos, Spyros
    van Tulder, Maurits W.
    Cuijpers, Pim
    Prigent, Amelie
    Chevreul, Karine
    Riper, Heleen
    Bosmans, Judith E.
    JOURNAL OF AFFECTIVE DISORDERS, 2017, 210 : 72 - 81
  • [43] Use of nitrous oxide in the treatment of major depressive disorder and treatment-resistant major depressive disorder: A systematic review and meta-analysis nitrous oxide in depressive disorders
    Rech, Peterson
    Custodio, Rodrigo Miranda
    Uggioni, Maria Laura Rodrigues
    Prestes, Gabriele Silveira
    Marcal, Fernanda
    Silveira, Vitoria Pedroso
    Dagostin, Valdemira Santina
    Colonetti, Tamy
    Rosa, Maria Ines
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2024, 129
  • [44] Mismatch negativity in patients with major depressive disorder: A meta-analysis
    Tseng, Yi-Jhan
    Nouchi, Rui
    Cheng, Chia-Hsiung
    CLINICAL NEUROPHYSIOLOGY, 2021, 132 (10) : 2654 - 2665
  • [45] Efficacy of Esketamine Augmentation in Major Depressive Disorder: A Meta-Analysis
    Papakostas, George, I
    Salloum, Naji C.
    Hock, Rebecca S.
    Jha, Manish K.
    Murrough, James W.
    Mathew, Sanjay J.
    Iosifescu, Dan, V
    Fava, Maurizio
    JOURNAL OF CLINICAL PSYCHIATRY, 2020, 81 (04)
  • [46] Efficacy of agomelatine in major depressive disorder: meta-analysis and appraisal
    Singh, Surendra P.
    Singh, Vidhi
    Kar, Nilamadhab
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 (03): : 417 - 428
  • [47] INHIBITED TEMPERAMENT IS A TRANSDIAGNOSTIC FACTOR ACROSS SCHIZOPHRENIA, PSYCHOTIC BIPOLAR DISORDER, AND MAJOR DEPRESSIVE DISORDER
    Feola, Brandee
    Armstrong, Kristan
    Woodward, Neil
    Heckers, Stephan
    Blackford, Jennifer
    SCHIZOPHRENIA BULLETIN, 2019, 45 : S278 - S279
  • [48] Meta-analysis of Functional Neuroimaging of Major Depressive Disorder in Youth
    Miller, Chris H.
    Hamilton, J. Paul
    Sacchet, Matthew D.
    Gotlib, Ian H.
    JAMA PSYCHIATRY, 2015, 72 (10) : 1045 - 1053
  • [49] Meta-analysis of placebo rates in major depressive disorder trials
    Stolk, P
    ten Berg, MJ
    Hemels, MEH
    Einarson, TR
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (12) : 1891 - 1899
  • [50] Meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder
    Kato, M.
    Serretti, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S327 - S327